# Nasdaq's Wild Ride: Bulls, Blood Filters, and Buzz! Newsy: Bud Fox's 3 Controversial Stocks of the Day Published: 2026-08-06T14:00:00.183Z Source: https://newsyai.com/edition/48822160-d3ed-489b-8d9a-645f8599ebd6 Archive: https://newsyai.com/newsy/bde0e0f6-7fac-4abb-93a8-996b5464e3e9.md --- **Nasdaq’s Reverse-Split Circus: Battery Dreams, Blood Filters & Data Hustlers – August 6, 2026 Edition!** Futures mixed (Dow still snoring, Nasdaq riding that AI/chip wave like it’s 2023 all over again, crude oil doing the volatility limbo). The MVLS $5M guillotine and repeat-split rules keep these nano-caps sweating bullets. Yesterday’s capital grinders, steel kitchens, and bot boners? Yesterday’s news. Fresh meat today: desperate-ratio plays where bulls chase compliance pops and sector moonshots, while bears smell endless dilution, cash bonfires, and governance face-plants.[[1]](https://finance.yahoo.com/calendar/splits/) ### 1) MVIS (MicroVision): “1-for-15 Lidar Stiffy vs. EV/AI Hype & Cash Burn Graveyard” **Why it’s loud** Brutal 1-for-15 reverse split effective recently (around Aug 3) to chase Nasdaq $1 bid compliance. Lidar tech play with EV and autonomy dreams—bulls eye any new auto contracts or AI sensor wins with the shrunken float; bears hammer chronic losses, repeated raises, and “microcap lidar cash burner” red flags.[[1]](https://finance.yahoo.com/calendar/splits/) **Bull case (compliance rocket + lidar erection)** 15x ratio + volume spike + any EV or robotics tailwind = $1–4+ rip. Ride the sensor fantasy, degens—tiny float turns noise into rocket fuel! **Bear case (dilution gangbang & split limp encore)** 15x still screams capital hunger in a high-burn space, zero consistent commercial traction, brutal competition = sub-$0.10 cemetery. Short the fade before the next offering tsunami! **My take, first principles (real lidar signal vs. listing cancer)** Genuine lidar IP offers short-term narrative juice in autonomy and robotics, but cash burn reality, dilution history, and stricter Nasdaq rules scream unsustainable trap. Narrative lottery with moonshot potential. Scalp the spunk? **$0.08–2.00** range, **$0.47C** lidar pump—**P$0.07** dilution fade. ### 2) AEMD (Aethlon Medical): “1-for-5 Blood Filter Boner vs. Biotech Burn & Compliance Hangover” **Why it’s loud** Savage 1-for-5 reverse split (effective Aug 4) chasing Nasdaq compliance. Blood purification tech play—bulls chase any FDA or clinical trial hype with the post-split float; bears hammer ongoing cash burn, dilution risks, and “microcap medtech graveyard” vibes.[[2]](https://capedge.com/stock-split-calendar) **Bull case (compliance stiffy + filter erection)** 5x desperation + volume pop + any medical breakthrough whisper = $1–3+ rip. Ride the purification fantasy, apes—shrunken float turns noise into rocket fuel! **Bear case (dilution gangbang & split limp encore)** 5x screams capital hunger, zero proven commercial traction, brutal clinical risks = sub-penny cemetery. Short the fade before the next offering tsunami! **My take, first principles (real filter signal vs. listing cancer)** Genuine blood purification IP offers short-term hype juice in biotech, but cash burn reality, dilution history, and stricter Nasdaq rules scream unsustainable trap. Sector lottery at best. Scalp it? **$0.09–1.80** range, **$0.46C** filter pump—**P$0.06** dilution fade. ### 3) WORX (SCWorx): “1-for-12 Data Hustler Stiffy vs. Governance Chaos & Execution Face-Plant” **Why it’s loud** Insane 1-for-12 reverse split (effective around Aug 3-4) amid MVLS pressure. AI healthcare data management play—bulls eye any partnership or sector rebound with the post-split float; bears hammer governance flags, execution risks, and “microcap data cash burner” red flags.[[3]](https://www.stocktitan.net/sec-filings/WORX/8-k-sc-worx-corp-reports-material-event-e73cd9f61655.html) **Bull case (compliance rocket + data erection)** 12x ratio + volume spike + any AI healthcare narrative = $1–4+ rip. Ride the data fantasy, degens—tiny float turns noise into rocket fuel! **Bear case (dilution gangbang & split limp encore)** 12x screams capital hunger, zero commercial traction yet, brutal competition = sub-$0.10 cemetery. Short the fade before the next offering tsunami! **My take, first principles (real data signal vs. listing cancer)** Genuine AI healthcare IP offers short-term narrative juice in data management, but cash burn reality, dilution history, and stricter Nasdaq rules scream unsustainable trap. Narrative lottery with moonshot potential. Scalp the spunk? **$0.07–1.75** range, **$0.45C** data pump—**P$0.06** dilution fade. **Tape-Side Tactics (MVIS Lidar Mayhem, AEMD Filter Grind & WORX Data Chaos – August 6 Edition)** - **MVIS**: **$0.08–2.00** stiffy; **$0.47C** lidar pump, **P$0.07** fade. - **AEMD**: **$0.09–1.80** stiffy; **$0.46C** filter pump, **P$0.06** fade. - **WORX**: **$0.07–1.75** stiffy; **$0.45C** data pump, **P$0.06** fade. New MVLS rules still tightening the noose amid crude cock-up and micro-madness. Balls-deep DYOR, NFA, degens duck the dilutions! **Sources** (for tracking every claim above): - Reverse splits & reactions: Nasdaq Trader Equity Corporate Actions Alerts, Yahoo Finance Stock Splits Calendar, StockTitan (Aug 2026 data). - Company announcements & details: Company IR sites, SEC filings via Yahoo Finance/StockTitan. - Nasdaq reverse-split rule changes & MVLS: SEC filings, Nasdaq Listing Rules (2026 updates). - Broader microcap/premarket context & volatility: Yahoo Finance, recent market data.